Lifecore Biomedical (NASDAQ: LFCR) — Perfil da empresa, notícias e dados financeiros
Lifecore Biomedical develops high-quality hyaluronic acid products for ophthalmic, orthopedic, and veterinary markets globally.
Lifecore Biomedical
Lifecore Biomedical (NASDAQ:LFCR) specializes in the development and manufacturing of high-quality hyaluronic acid (HA) products for the ophthalmic, orthopedic, and veterinary markets globally. Rooted in a commitment to innovation and quality, Lifecore is dedicated to leveraging its expertise in HA technology to provide advanced solutions that enhance patient care. The company's objectives revolve around expanding its product offerings through strategic research and development while maintaining the highest standards of excellence in manufacturing. Lifecore aims to grow its market presence and meet the evolving needs of its customer base by focusing on sustainable practices and cutting-edge technology advancements in the biomedical field.
Resumo
Operações
Produtos e/ou serviços de Lifecore Biomedical
- Hyaluronic acid (HA) production for medical applications, including ophthalmic surgery, orthopedics, and wound care.
- Development of injectable HA for aesthetic enhancements like dermal fillers.
- Contract development and manufacturing organization (CDMO) services, offering process development, filling, and packaging for pharmaceuticals.
- Agricultural applications of HA, focusing on the delivery of nutrients and pesticides to plants.
- Veterinary HA products aimed at joint health and surgical aids for pets and livestock.
- Manufacture of HA-based products for personal care, such as moisturizers and anti-aging skincare.
equipe executiva do Lifecore Biomedical
- Paul JosephsPresident, CEO & Director
- Ryan D. LakeExecutive VP & CFO
- Thomas D. SalusChief Legal & Administration Officer and Corporate Secretary
- Thomas GuldagerVice President of Operations
- Aaron PerlitshDirector of Internal Audit & Chief Compliance Officer
- Jackie Q. KleckerExecutive Vice President of Quality & Development Services
- Mark DaFonsecaChief Commercial Officer
- Parker K. JavidVice President
Principais indicadores financeiros
Resultados divulgados pela Lifecore Biomedical, em USD.
- Cap. de mercado
- 244,1 mi
- Receita (TTM)
- 129,5 mi
- P/L
- —
- LPA (diluído, TTM)
- -1.3
- Dividend yield
- —
- Margem de lucro
- -23.8%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 129,5 mi | -1,3 mi | -30,8 mi | |
| 128,9 mi | -17,2 mi | -38,7 mi | |
| 128,3 mi | -8,8 mi | 12 mi | |
| 111,3 mi | -11,8 mi | -116,7 mi |